tetano
Editor, Senior Moderator
Acta Diabetol
. 2020 Aug 17;1-6.
doi: 10.1007/s00592-020-01592-8. Online ahead of print.
The relationship between diabetes and clinical outcomes in COVID-19: a single-center retrospective analysis
Tamaryn Fox[SUP] 1 [/SUP], Kathleen Ruddiman[SUP] 2 [/SUP], Kevin Bryan Lo[SUP] 2 [/SUP], Eric Peterson[SUP] 2 [/SUP], Robert DeJoy 3rd[SUP] 2 [/SUP], Grace Salacup[SUP] 2 [/SUP], Jerald Pelayo[SUP] 2 [/SUP], Ruchika Bhargav[SUP] 2 [/SUP], Fahad Gul[SUP] 2 [/SUP], Jeri Albano[SUP] 2 [/SUP], Zurab Azmaiparashvili[SUP] 2 [/SUP], Catherine Anastasopoulou[SUP] 2 3 4 [/SUP], Gabriel Patarroyo-Aponte[SUP] 2 4 5 [/SUP]
Affiliations
Abstract
Aims: Coronavirus disease 19 (COVID-19) has become a pandemic. Diabetic patients tend to have poorer outcomes and more severe disease (Kumar et al. in Diabetes Metab Syndr 14(4):535-545, 2020. https://doi.org/10.1016/j.dsx.2020.04.044 ). However, the vast majority of studies are representative of Asian and Caucasian population and fewer represent an African-American population.
Methods: In this single-center, retrospective observational study, we included all adult patients (> 18 years old) admitted to Einstein Medical Center, Philadelphia, with a diagnosis of COVID-19. Patients were classified according to having a known diagnosis of diabetes mellitus. Demographic and clinical data, comorbidities, outcomes and laboratory findings were obtained.
Results: Our sample included a total of 355 patients. 70% were African-American, and 47% had diabetes. Patients with diabetes had higher peak inflammatory markers like CRP 184 (111-258) versus 142 (65-229) p = 0.012 and peak LDH 560 (384-758) versus 499 (324-655) p = 0.017. The need for RRT/HD was significantly higher in patients with diabetes (21% vs 11% p = 0.013) as well as the need for vasopressors (28% vs 18% p = 0.023). Only age was found to be an independent predictor of mortality. We found no significant differences in inpatient mortality p = 0.856, need for RRT/HD p = 0.429, need for intubation p = 1.000 and need for vasopressors p = 0.471 in African-Americans with diabetes when compared to non-African-Americans.
Conclusions: Our study demonstrates that patients with COVID-19 and diabetes tend to have more severe disease and poorer clinical outcomes. African-American patients with diabetes did not differ in outcomes or disease severity when compared to non-African-American patients.
Keywords: COVID-19; Diabetes; Mortality; Novel coronavirus; Outcomes.
. 2020 Aug 17;1-6.
doi: 10.1007/s00592-020-01592-8. Online ahead of print.
The relationship between diabetes and clinical outcomes in COVID-19: a single-center retrospective analysis
Tamaryn Fox[SUP] 1 [/SUP], Kathleen Ruddiman[SUP] 2 [/SUP], Kevin Bryan Lo[SUP] 2 [/SUP], Eric Peterson[SUP] 2 [/SUP], Robert DeJoy 3rd[SUP] 2 [/SUP], Grace Salacup[SUP] 2 [/SUP], Jerald Pelayo[SUP] 2 [/SUP], Ruchika Bhargav[SUP] 2 [/SUP], Fahad Gul[SUP] 2 [/SUP], Jeri Albano[SUP] 2 [/SUP], Zurab Azmaiparashvili[SUP] 2 [/SUP], Catherine Anastasopoulou[SUP] 2 3 4 [/SUP], Gabriel Patarroyo-Aponte[SUP] 2 4 5 [/SUP]
Affiliations
- PMID: 32804317
- PMCID: PMC7429932
- DOI: 10.1007/s00592-020-01592-8
Abstract
Aims: Coronavirus disease 19 (COVID-19) has become a pandemic. Diabetic patients tend to have poorer outcomes and more severe disease (Kumar et al. in Diabetes Metab Syndr 14(4):535-545, 2020. https://doi.org/10.1016/j.dsx.2020.04.044 ). However, the vast majority of studies are representative of Asian and Caucasian population and fewer represent an African-American population.
Methods: In this single-center, retrospective observational study, we included all adult patients (> 18 years old) admitted to Einstein Medical Center, Philadelphia, with a diagnosis of COVID-19. Patients were classified according to having a known diagnosis of diabetes mellitus. Demographic and clinical data, comorbidities, outcomes and laboratory findings were obtained.
Results: Our sample included a total of 355 patients. 70% were African-American, and 47% had diabetes. Patients with diabetes had higher peak inflammatory markers like CRP 184 (111-258) versus 142 (65-229) p = 0.012 and peak LDH 560 (384-758) versus 499 (324-655) p = 0.017. The need for RRT/HD was significantly higher in patients with diabetes (21% vs 11% p = 0.013) as well as the need for vasopressors (28% vs 18% p = 0.023). Only age was found to be an independent predictor of mortality. We found no significant differences in inpatient mortality p = 0.856, need for RRT/HD p = 0.429, need for intubation p = 1.000 and need for vasopressors p = 0.471 in African-Americans with diabetes when compared to non-African-Americans.
Conclusions: Our study demonstrates that patients with COVID-19 and diabetes tend to have more severe disease and poorer clinical outcomes. African-American patients with diabetes did not differ in outcomes or disease severity when compared to non-African-American patients.
Keywords: COVID-19; Diabetes; Mortality; Novel coronavirus; Outcomes.